ADVI’s Lindsay Bealor Greenleaf sat down with CNBC to share her thoughts on the White House’s recent executive orders on drug pricing reform, and how the proposal could have unintended consequences leading to increased Medicare spending
ADVI’s Lindsay Bealor Greenleaf sat down with CNBC to share her thoughts on the White House’s recent executive orders on drug pricing reform, and how the proposal could have unintended consequences leading to increased Medicare spending.
[el-text]
***excerpt***
ADVI’s Lindsay Bealor Greenleaf sat down with CNBC to share her thoughts on the White House’s recent executive orders on drug pricing reform, and how the proposal could have unintended consequences leading to increased Medicare spending.
***end excerpt***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.